NCT02273843View on ClinicalTrials.gov

A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
PrematurityLate-onset Sepsis
Interventions
DRUG

High-dose vitamin D 3

Will receive oral cholecalciferol (vitamin D3) in a single daily dose of 800 IU from the time of diagnosis of sepsis until discharge from the NICU

DRUG

Conventional-Dose Vitamin D 3

Will receive oral cholecalciferol (vitamin D3) in a single daily dose of 400 IU from the time of diagnosis of sepsis until discharge from the NICU

Trial Locations (1)

35516

Neonatal Intensive Care Unit, Mansoura University Children Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University Children Hospital

OTHER

NCT02273843 - A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis | Biotech Hunter | Biotech Hunter